Latest / Investopedia Markets News (all except PF)
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca
AstraZeneca completed a direct listing on the New York Stock Exchange back in February, after delisting its American Depositary Receipts from the NasdaqCredit: Michael Nagle / Bloomberg via Getty ImagesKey TakeawaysBristol Myers Squibb shares rose Monday following reports of merger talks with AstraZeneca.Such a deal could create a drugmaker valued at nearly $400 billion. Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.Shares of Bristol Myers Squibb (BMY) were up over 4% in premarket trading to their highest point since early 2023…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.